These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8228628)

  • 21. [Superantigens and antigen recognition of T lymphocytes].
    Gülmezoğlu E
    Mikrobiyol Bul; 1993 Apr; 27(2):164-70. PubMed ID: 8502189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding kinetics of superantigen with TCR and MHC class II.
    Alam SM; Gascoigne NR
    Methods Mol Biol; 2003; 214():65-85. PubMed ID: 12489455
    [No Abstract]   [Full Text] [Related]  

  • 23. Conservation and variation in superantigen structure and activity highlighted by the three-dimensional structures of two new superantigens from Streptococcus pyogenes.
    Arcus VL; Proft T; Sigrell JA; Baker HM; Fraser JD; Baker EN
    J Mol Biol; 2000 May; 299(1):157-68. PubMed ID: 10860729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Superantigens and their behavior in the immune response].
    López H; Sandoval GF; Vera JG; Solano MO
    Rev Alerg Mex; 1996; 43(1):13-7. PubMed ID: 8901035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Processing and major histocompatibility complex binding of the MTV7 superantigen.
    Winslow GM; Marrack P; Kappler JW
    Immunity; 1994 Apr; 1(1):23-33. PubMed ID: 7889395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional analysis of the env open reading frame in human endogenous retrovirus IDDMK(1,2)22 encoding superantigen activity.
    Lapatschek M; Dürr S; Löwer R; Magin C; Wagner H; Miethke T
    J Virol; 2000 Jul; 74(14):6386-93. PubMed ID: 10864649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Searching for superantigens.
    Schlievert PM
    Immunol Invest; 1997; 26(1-2):283-90. PubMed ID: 9037631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions between staphylococcal superantigens and MHC class II molecules.
    Labrecque N; Thibodeau J; Sékaly RP
    Semin Immunol; 1993 Feb; 5(1):23-32. PubMed ID: 8467091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacterial and retroviral superantigens share a common binding region on class II MHC antigens.
    Torres BA; Griggs ND; Johnson HM
    Nature; 1993 Jul; 364(6433):152-4. PubMed ID: 8391645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. H2-O inhibits presentation of bacterial superantigens, but not endogenous self antigens.
    Qi L; Ostrand-Rosenberg S
    J Immunol; 2001 Aug; 167(3):1371-8. PubMed ID: 11466355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MHC class II hierarchy of superantigen presentation predicts efficiency of infection with mouse mammary tumor virus.
    Held W; Waanders GA; MacDonald HR; Acha-Orbea H
    Int Immunol; 1994 Sep; 6(9):1403-7. PubMed ID: 7819149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different superantigens interact with distinct sites in the Vbeta domain of a single T cell receptor.
    Hong SC; Waterbury G; Janeway CA
    J Exp Med; 1996 Apr; 183(4):1437-46. PubMed ID: 8666902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic down-modulators of staphylococcal superantigen-induced inflammation and toxic shock.
    Krakauer T
    Toxins (Basel); 2010 Aug; 2(8):1963-83. PubMed ID: 22069668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxoplasma gondii possesses a superantigen activity that selectively expands murine T cell receptor V beta 5-bearing CD8+ lymphocytes.
    Denkers EY; Caspar P; Sher A
    J Exp Med; 1994 Sep; 180(3):985-94. PubMed ID: 8064244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Superantigens: supersignalers?
    Zamoyska R
    Sci STKE; 2006 Oct; 2006(358):pe45. PubMed ID: 17062896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
    Lamphear JG; Stevens KR; Rich RR
    J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbial superantigens: from structure to function.
    Papageorgiou AC; Acharya KR
    Trends Microbiol; 2000 Aug; 8(8):369-75. PubMed ID: 10920396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for a viral superantigen in humans.
    Lafon M; Lafage M; Martinez-Arends A; Ramirez R; Vuillier F; Charron D; Lotteau V; Scott-Algara D
    Nature; 1992 Aug; 358(6386):507-10. PubMed ID: 1386410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of MHC class II-associated peptides that promote the presentation of toxic shock syndrome toxin-1 to T cells.
    Hogan RJ; VanBeek J; Broussard DR; Surman SL; Woodland DL
    J Immunol; 2001 Jun; 166(11):6514-22. PubMed ID: 11359802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of peptide-major histocompatibility complex tetramer technology to study interactions between Staphylococcus aureus proteins and human cells.
    Massey RC; Scriba TJ; Brown EL; Phillips RE; Sewell AK
    Infect Immun; 2007 Dec; 75(12):5711-5. PubMed ID: 17938227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.